AGILENT TECHNOLOGIES, INC. Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents
AGILENT TECHNOLOGIES, INC. (A) reported Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents of $2.00 million for the 9-month period ending 2026-07-31, per its 10-Q filed 2026-09-01.
Financial Statements › Cash Flow › Change in Cash
us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-09-01
- AGILENT TECHNOLOGIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2026-01-31 was $16.00M.
- AGILENT TECHNOLOGIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2025-01-31 was -$19.00M, a 371.43% decline year-over-year.
- AGILENT TECHNOLOGIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2024-01-31 was $7.00M, a 68.18% decline year-over-year.
- AGILENT TECHNOLOGIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for the quarter ending 2023-01-31 was $22.00M.
- AGILENT TECHNOLOGIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2025 was $9.00M.
- AGILENT TECHNOLOGIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2024 was -$2.00M, a 140.00% decline from fiscal 2023.
- AGILENT TECHNOLOGIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2023 was $5.00M.
- AGILENT TECHNOLOGIES, INC. effect of exchange rate on cash, cash equivalents, restricted cash and restricted cash equivalents for fiscal 2020 was $2.00M.
| Period end | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 9 month | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 12 month |
|---|---|---|---|---|
| 2026-07-31 | $2.00M 10-Q · filed 2026-09-01 | |||
| 2026-04-30 | $9.00M 10-Q · filed 2026-06-01 | |||
| 2026-01-31 | $16.00M 10-Q · filed 2026-03-03 | |||
| 2025-10-31 | $9.00M 10-K · filed 2025-12-22 | |||
| 2025-07-31 | $10.00M 10-Q · filed 2026-09-01 | |||
| 2025-04-30 | $9.00M 10-Q · filed 2026-06-01 | |||
| 2025-01-31 | -$19.00M 10-Q · filed 2026-03-03 | |||
| 2024-10-31 | -$2.00M 10-K · filed 2025-12-22 | |||
| 2024-07-31 | $0.00 10-Q · filed 2025-08-29 | |||
| 2024-04-30 | -$2.00M 10-Q · filed 2025-06-02 | |||
| 2024-01-31 | $7.00M 10-Q · filed 2025-03-03 | |||
| 2023-10-31 | $5.00M 10-K · filed 2025-12-22 | |||
| 2023-07-31 | $19.00M 10-Q · filed 2024-08-30 | |||
| 2023-04-30 | $16.00M 10-Q · filed 2024-06-03 | |||
| 2023-01-31 | $22.00M 10-Q · filed 2024-03-05 | |||
| 2022-10-31 | -$36.00M 8-K · filed 2025-03-03 | |||
| 2022-07-31 | -$22.00M 10-Q · filed 2023-08-31 | |||
| 2022-04-30 | -$16.00M 10-Q · filed 2023-05-26 | |||
| 2022-01-31 | -$4.00M 10-Q · filed 2023-03-03 | |||
| 2021-10-31 | $3.00M 8-K · filed 2024-09-03 | |||
| 2021-07-31 | $6.00M 10-Q · filed 2022-09-01 | |||
| 2021-04-30 | $9.00M 10-Q · filed 2022-05-31 | |||
| 2020-10-31 | $2.00M 10-K · filed 2022-12-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| WATERS CORP /DE/ (WAT) | United States | $42.297B | 224.28 |
| ILLUMINA, INC. (ILMN) | United States | $41.357B | 32.37 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |